Retatrutide 10 to 60 mg
Triple GIP, GLP-1 and glucagon agonist · in phase 3
A single peptide that activates three receptors at once: GIP, GLP-1 and glucagon. The glucagon arm adds increased energy expenditure to the appetite effect of the other two. It produced the largest weight reduction in phase 2 of this whole group, but it is not approved in any country and its phase 3 obesity programme has not yet published results.
CAS: 2381089-83-2. Lyophilized powder: -20 °C, stable.
Articles
- Retatrutide in Costa Rica: what it is, what is known, and why the lab report matters
- Retatrutide vs tirzepatide: two receptors against three, and how much evidence each one has
- Retatrutide 10 mg: $115
- Retatrutide 15 mg: $145
- Retatrutide 20 mg: $205
- Retatrutide 30 mg: $265
- Retatrutide 48 mg: $310
- Retatrutide 60 mg: $345
For research use only. Not for human consumption.